Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus
Publication date
2023-04
Authors
Trials@Home Consortium
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
There is increasing interest in clinical trials that use technologies and other innovative operational approaches to organise trial activities around trial participants instead of investigator sites. A range of terms has been introduced to refer to this operational clinical trial model, including virtual, digital, remote, and decentralised clinical trials (DCTs). However, this lack of standardised terminology can cause confusion over what a particular trial model entails and for what purposes it can be used, hampering discussions by stakeholders on its acceptability and suitability. Here, we review the different terms described in the scientific literature, advocate the consistent use of a unified term, ‘decentralised clinical trial,’ and provide a detailed definition of this term.
Keywords
decentralised clinical trial, direct-to-patient, patient-centric, remote clinical trial, telemedicine, virtual clinical trial, Pharmacology, Drug Discovery
Citation
Trials@Home Consortium 2023, 'Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus', Drug Discovery Today, vol. 28, no. 4, 103520. https://doi.org/10.1016/j.drudis.2023.103520